NMR demonstrates superior value investment characteristics with a higher Zacks Rank (#2 Buy), significantly lower forward P/E ratio (10.22), better PEG ratio (1.13), lower P/B ratio (1.17), and a strong Value grade of B, making it the preferred choice for value investors.
Articles that tag NMR but are mainly about other companies.
Added to Zacks Rank #1 Strong Buy list with 22.5% increase in consensus earnings estimate over 60 days
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
